EPIX

1.60

0.00% 0.00

Dopo l'orario di chiusura: 1.61 0.01 +0.63%

Essa Pharma Inc (EPIX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.60

Aprire:

$1.58

Volume 24 ore:

245.29K

Relative Volume:

0.29

Capitalizzazione di mercato:

$71.02M

Reddito:

Utile/perdita netta:

$-28.54M

Rapporto P/E:

-2.5806

EPS:

-0.62

Flusso di cassa netto:

$-22.72M

1 W Prestazione:

-2.44%

1M Prestazione:

-7.51%

6M Prestazione:

-67.87%

1 anno Prestazione:

-73.77%

Intervallo 1D:

$1.58

$1.64

Intervallo di 1 settimana:

$1.57

$1.69

Portata 52W:

$1.40

$11.67

Essa Pharma Inc Stock (EPIX) Company Profile

Nome

Essa Pharma Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

(778) 331-0962

Indirizzo

SUITE 720, VANCOUVER, BC

Dipendente

Cinguettio

@essapharma

Prossima data di guadagno

2024-08-06

Ultimi documenti SEC

EPIX's Discussions on Twitter

Confronta EPIX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EPIX Essa Pharma Inc	1.60	71.02M	0	-28.54M	-22.72M	-0.64
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-04	Downgrade	Jefferies	Buy → Hold
2024-11-04	Downgrade	Oppenheimer	Outperform → Perform
2024-11-04	Downgrade	Piper Sandler	Overweight → Neutral
2023-06-26	Ripresa	Oppenheimer	Outperform
2021-03-04	Iniziato	Piper Sandler	Overweight
2021-01-11	Reiterato	H.C. Wainwright	Buy
2020-11-02	Iniziato	Jefferies	Buy
2019-10-25	Iniziato	Oppenheimer	Outperform

Mostra tutto

Essa Pharma Inc Borsa (EPIX) Ultime notizie

09:00 AM

Surprising News! ESSA Pharma’s Big Breakthrough Expected Soon. - Jomfruland.net

09:00 AM

07:59 AM

When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? - Yahoo Finance

07:59 AM

Dec 18, 2024

ESSA Pharma’s Cash Management: A Potential Risk to Shareholder Value and Market Stability - TipRanks

Dec 18, 2024

Dec 17, 2024

ESSA Pharma Inc. Reports Strategic Shift Amid Losses - TipRanks

Dec 17, 2024

ESSA Pharma: Fiscal Q4 Earnings Snapshot - The Ridgefield Press

Dec 17, 2024

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 - Barchart

Dec 17, 2024

ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com

Dec 17, 2024

ESSA Pharma (NASDAQ:EPIX) Issues Quarterly Earnings Results - MarketBeat

Dec 17, 2024

SEC Form 10-K filed by ESSA Pharma Inc. - Quantisnow

Dec 17, 2024

ESSA Pharma Halts Key Cancer Drug Trials, Initiates Strategic Review Amid Clinical Setback - StockTitan

Dec 17, 2024

Dec 16, 2024

ESSA Pharma ends long-standing license agreement with cancer agencies - Investing.com

Dec 16, 2024

Dec 08, 2024

ESSA Pharma Inc. Adopts Executive Severance Plan**United States Securities and Exchange Commission Filing – ESSA Pharma Inc. submitted a current report on Form 8-K, dated June 5, 2024, announcing the adoption of the ESSA Pharma Inc. Severance P - Defense World

Dec 08, 2024

Dec 06, 2024

ESSA Pharma Introduces New Executive Severance Plan - TipRanks

Dec 06, 2024

Dec 05, 2024

RTW Investments LP Grows Stake in ESSA Pharma Inc. (NASDAQ:EPIX) - MarketBeat

Dec 05, 2024

Dec 03, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc.EPIX - PR Newswire

Dec 03, 2024

Dec 02, 2024

Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session - MSN

Dec 02, 2024

Nov 20, 2024

Piper Sandler Downgrades ESSA Pharma (EPIX) - MSN

Nov 20, 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN

Nov 20, 2024

Thinking about buying stock in Adverum Biotechnologies, Roma Gre - GuruFocus.com

Nov 20, 2024

ESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat

Nov 14, 2024

Nov 10, 2024

ESSA Pharma And 2 Other US Penny Stocks To Watch - Yahoo Finance

Nov 10, 2024

Nov 08, 2024

Jones Trading Downgrades ESSA Pharma (EPIX) - MSN

Nov 08, 2024

ESSA Pharma (NASDAQ:EPIX) Lowered to Market Perform Rating by Oppenheimer - Defense World

Nov 08, 2024

ESSA Pharma (NASDAQ:EPIX) Rating Lowered to Neutral at Piper Sandler - Defense World

Nov 08, 2024

Nov 06, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ESSA Pharma Inc. (EPIX) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Nov 06, 2024

Nov 05, 2024

Finance Watch: Syndax Raises $350m, KalVista Gets $100m In Royalty Deals - Citeline News & Insights

Nov 05, 2024

Growth N. V. Biotech Sells 7,879,583 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) Stock - MarketBeat

Nov 05, 2024

Bb biotech ag sells Essa Pharma shares for $12 million - Investing.com

Nov 05, 2024

Bb biotech ag sells Essa Pharma shares for $12 million By Investing.com - Investing.com UK

Nov 05, 2024